150 related articles for article (PubMed ID: 31576517)
1. Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer.
Liao S; Ou M; Lai L; Lin H; Zou Y; Yu Y; Li X; Dai Y; Sui W
Genes Genomics; 2019 Dec; 41(12):1493-1503. PubMed ID: 31576517
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of transcriptome and proteome to explore the genes related to steroid-induced femoral head necrosis.
Yang N; Wang H; Zhang W; Sun H; Li M; Xu Y; Huang L; Geng D
Exp Cell Res; 2021 Apr; 401(1):112513. PubMed ID: 33567325
[TBL] [Abstract][Full Text] [Related]
3. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
4. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
5. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
Bi D; Ning H; Liu S; Que X; Ding K
Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
7. Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Zhang Y; Fang L; Zang Y; Xu Z
Med Sci Monit; 2018 May; 24():3024-3033. PubMed ID: 29739919
[TBL] [Abstract][Full Text] [Related]
8. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
[TBL] [Abstract][Full Text] [Related]
9. Combined transcriptomics and proteomics forecast analysis for potential genes regulating the Columbian plumage color in chickens.
Wang X; Li D; Song S; Zhang Y; Li Y; Wang X; Liu D; Zhang C; Cao Y; Fu Y; Han R; Li W; Liu X; Sun G; Li G; Tian Y; Li Z; Kang X
PLoS One; 2019; 14(11):e0210850. PubMed ID: 31693656
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic analysis of microRNA-mRNA expression profiles of bladder tissue induced by bladder outlet obstruction in a rat model.
Duan LJ; Cao QF; Xu D; Liu HL; Qi J
Mol Med Rep; 2017 Oct; 16(4):4803-4810. PubMed ID: 28791388
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target.
Puttamallesh VN; Deb B; Gondkar K; Jain A; Nair B; Pandey A; Chatterjee A; Gowda H; Kumar P
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32650368
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of mRNA-m
Wu B; Jiang X; Huang Y; Ying X; Zhang H; Liu B; Li Z; Qi D; Ji W; Cai X
Biomarkers; 2021 Sep; 26(6):499-507. PubMed ID: 33830842
[No Abstract] [Full Text] [Related]
14. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
15. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
Cao YP; Zhou J; Li WJ; Shao Y; Zheng SY; Tian T; Xie KP; Yan X
Cell Physiol Biochem; 2018; 50(3):1154-1163. PubMed ID: 30355928
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.
Li M; Liu Y; Zhang X; Liu J; Wang P
Gene; 2018 Nov; 677():189-197. PubMed ID: 30025927
[TBL] [Abstract][Full Text] [Related]
19. Screening candidate genes associated with bladder cancer using DNA microarray.
Xu A; Wang C; Sun S
Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
[TBL] [Abstract][Full Text] [Related]
20. Seedless mutant 'Wuzi Ougan' (Citrus suavissima Hort. ex Tanaka 'seedless') and the wild type were compared by iTRAQ-based quantitative proteomics and integratedly analyzed with transcriptome to improve understanding of male sterility.
Zhang C; Yu D; Ke F; Zhu M; Xu J; Zhang M
BMC Genet; 2018 Nov; 19(1):106. PubMed ID: 30458706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
